– USA, VA – ReAlta Life Sciences, Inc., a mid-stage clinical biotech company dedicated to saving lives by rebalancing the inflammatory response to address life-threatening diseases, today announced the appointment of Dr.…
– USA, MA – Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs, today announced the appointment of Dr.…
– UK, Oxford – Physiomics plc (LON: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalized medicine solutions, today announced the appointment of current COO Dr.…
– FRANCE, Paris – GenSight Biologics (EPA: SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the co-optation of CEO Laurence Rodriguez to its Board of Directors, replacing Bernard Gilly who resigned from the Board.…
– USA, MA – Bone Biologics Corporation (Nasdaq: BBLG/BLGW), a developer of orthobiologic products for spine fusion markets, today announced the appointment of Rob Gagnon to its Board of Directors effective immediately, filling the seat left by Erick Lucera, who resigned effective today.…
